Počet záznamů: 1  

PLCL/PCL dressings with platelet lysate and growth factors embedded in fibrin for chronic wound regeneration

  1. 1.
    SYSNO ASEP0568881
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevPLCL/PCL dressings with platelet lysate and growth factors embedded in fibrin for chronic wound regeneration
    Tvůrce(i) Táborská, Johanka (UMCH-V)
    Blanquer, Andreu (FGU-C) RID, ORCID
    Brynda, Eduard (UMCH-V) RID
    Filová, Elena (FGU-C) RID, ORCID
    Stiborová, Lenka (UMCH-V)
    Jenčová, V. (CZ)
    Havlíčková, K. (CZ)
    Riedelová, Zuzana (UMCH-V) ORCID
    Riedel, Tomáš (UMCH-V) RID, ORCID
    Zdroj.dok.International Journal of Nanomedicine. - : Dove Medical Press
    Roč. 18, 3 February (2023), s. 595-610
    Poč.str.16 s.
    Jazyk dok.eng - angličtina
    Země vyd.NZ - Nový Zéland
    Klíč. slovahuman platelet lysate ; diabetic ulcer ; fibrin coating
    Vědní obor RIVFB - Endokrinologie, diabetologie, metabolizmus, výživa
    Obor OECDEndocrinology and metabolism (including diabetes, hormones)
    CEPNV18-01-00332 GA MZd - Ministerstvo zdravotnictví
    LX22NPO5104 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Způsob publikováníOpen access
    Institucionální podporaUMCH-V - RVO:61389013 ; FGU-C - RVO:67985823
    UT WOS000928064400001
    EID SCOPUS85147762343
    DOI10.2147/IJN.S393890
    AnotaceThe formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ϵ-caprolactone) and poly(ϵ-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.
    PracovištěÚstav makromolekulární chemie
    KontaktEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Rok sběru2024
    Elektronická adresahttps://www.dovepress.com/plclpcl-dressings-with-platelet-lysate-and-growth-factors-embedded-in--peer-reviewed-fulltext-article-IJN
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.